Many practitioners refer eczema clients out, or treat them cautiously and hope for the best. That caution comes from caring about the client, and it’s the right instinct. And because eczema starts at the barrier, a skilled practitioner can do far more for these clients than most realize.
Do you turn eczema clients away, or watch them flare after treatment? Let’s talk about how to support them.
What it costs your practice
Eczema is one of the most common conditions your clients live with. When a practice can’t support it confidently, the losses add up quietly:
- A whole group of clients you can’t fully serve
- Retail you never sell, because nothing on your shelf feels safe for their skin
- Flares after treatment that cost you the client’s trust
- Clients you refer out who never come back for anything else
You rarely notice these losses adding up. Each one just looks like a client who didn’t come back. More often, she left the consult without understanding why her skin keeps flaring, or what her current routine is doing to it. The plan felt like one more product to try, and the practice lost a client it could have helped.
The itch that rashes, not the rash that itches
Eczema and dermatitis mean the same thing: a pattern of inflammation with more than one possible trigger. Atopic dermatitis is the most common type. Contact dermatitis is another, caused by irritants or allergens, with irritant contact dermatitis being more common. It varies not only in severity but in where it appears, what sets it off, when it starts, and which part of the barrier is failing.
Much of the frustration comes from the itch itself. It often starts before anything is visible, sometimes on skin that looks completely normal. Much of what you eventually see is damage from scratching. That’s why eczema is called the itch that rashes, not the rash that itches.
Where eczema begins
There are two main scientific views.
- The inside out view: the immune system goes wrong first and then harms the skin.
- The outside in view: the barrier fails first, letting irritants and allergens in, which then triggers the immune system.
Dr. Peter Elias, a dermatologist and barrier researcher at the University of California, San Francisco, has spent forty years supporting the outside in view with Dr. Mary Williams. Their research shows that the strongest genetic links in atopic dermatitis sit in the genes that build the skin barrier, not the genes that control the immune system.
There is a fair counterpoint. Biologic drugs that block two immune signals, interleukin 4 and interleukin 13, work very well, which makes it easy to call eczema an immune disease. But those drugs also help restore filaggrin and barrier lipids, so their success doesn’t tell us which problem came first.
Elias describes a cycle. The barrier fails, inflammation follows, inflammation slows barrier repair, and itching leads to scratching, which keeps the cycle going. His central point is that calming inflammation alone doesn’t fix the underlying barrier problem. He isn’t against medication and supports biologics for severe or stubborn cases.
For a practitioner, that cycle is the opening. You can work on both sides of it: rebuilding the barrier and calming the inflammation that follows, and recognizing when the skin needs a doctor.
How the skin barrier breaks down, and what you’ll see
The barrier rarely fails in just one way. Most clients have several things going wrong at once, which is a big part of why eczema is so stubborn.
Filaggrin runs low:
Filaggrin holds the skin’s structural fibers together, then breaks down into Natural Moisturizing Factor, which helps the skin hold water and keeps the surface slightly acidic. You’ll often read that people with eczema carry a filaggrin gene mutation, but most don’t. The variants are real, but they appear in a minority of patients and vary by genetic background. Filaggrin can drop with no gene fault at all, because inflammation signals the skin to make less of it, and scratching, harsh cleansing, and dry air strip away what’s there.
In the treatment room: tight, dry skin that absorbs product and never stays comfortable for long.
The acid mantle drifts:
Healthy skin sits at a pH of about 4.5 to 5.5 and moves toward neutral in eczema. Traditional soap is pH 9 to 10. A higher pH switches on enzymes that loosen the bonds between skin cells, slows the enzymes that build barrier lipids, and makes the surface more welcoming to Staphylococcus aureus, a bacterium linked to flares.
In the treatment room: clients who flare after washing, or after any cleanser that leaves the skin squeaky clean.
The barrier lipids fall out of balance:
Ceramides, cholesterol, and free fatty acids work as a blend. In eczema the balance between them shifts, not only the amounts, so the barrier can’t seal the way it should.
In the treatment room: skin that looks better for an hour after moisturizer, then tightens again.
Shedding stops working:
Desquamation needs enough water to happen cleanly. When the outer layer is dry, cells stick together and come off in clumps.
In the treatment room: rough, flaking patches that keep coming back no matter how much product the client applies.
The skin thickens, not thins:
Over time, eczema thickens the skin. The thinning people associate with eczema comes from prolonged topical steroid use, not the condition itself, which is one more reason steroid decisions belong with the prescribing doctor.
In the treatment room: leathery, lined patches where the client scratches most.
Why moisturizing alone doesn’t fix it
Moisturizing is only one part of eczema support. Occlusive moisturizers sit on the surface and slow water loss, but they don’t rebuild the structure underneath. Used over time, occlusion can also quiet the skin’s own repair signals and create what Dr. Hans Lautenschläger calls a moisture trap: water held in the horny layer under the film, loosening the lipid layers that hold it together.
What rebuilds the barrier is the right lipids in the right balance. Elias and his colleagues showed that the balance matters more than the amount. The skin needs ceramides, cholesterol, and fatty acids together. Give it one or two and recovery slows. Give it all three in the right ratio and recovery speeds up.
That balance is the thinking behind Derma Membrane Structure (DMS), which copies how the skin arranges its own barrier lipids. Creams built this way support the barrier with substances it recognizes, without the emulsifiers that wash its own lipids away.
This is the foundation of corneotherapy. It repairs the stratum corneum first, rather than waiting for inflammation to be under control, because a stronger barrier gives inflammation less to react to. A damaged barrier prompts the skin to release inflammatory signals and lets irritants through. Restoring it reduces what sets the inflammation off. The idea dates to the 1960s, and Dr. Lautenschläger built it into a working system from clinical practice, reaching the same conclusion Elias reached in the lab.
What eczema skin needs from your home care plan
Because eczema varies so much in where it shows up, what triggers it, and where the barrier fails, the first question isn’t what’s on the shelf. It’s what this client’s skin is missing. The consultation decides. These are the needs you’ll see most often, with examples of how dermaviduals addresses each one.
- Cleansing that doesn’t strip. Cleansing Milk with DMS is free of tensides and uses the same layered structure as the base creams, so it adds barrier lipids while it cleans. It addresses both surfactant damage and the drifting acid mantle.
- Barrier lipids in the skin’s own arrangement. DMS Base Cream High Classic contains no emulsifiers and is built with phosphatidylcholine, a barrier supporting ingredient.
- Moisture binding for very dry, cracked skin. Oleogel N contains urea, which acts as a Natural Moisturizing Factor and helps calm itching.
- Local delivery of linoleic acid. People with eczema usually have normal blood levels of essential fatty acids. The problem is local, in how the skin converts them into barrier lipids. Evening Primrose Oil Nanoparticles deliver linoleic acid directly to the skin to help strengthen the barrier.
- Calm for inflamed, red skin. Oleogel S uses phosphatidylserine in a base with no water and is designed for inflamed skin.
Where your role begins and ends
Practitioners don’t diagnose eczema. Any client you suspect has eczema should be encouraged to get a medical diagnosis, and a client whose skin is severe, widespread, infected, or worsening quickly should be assessed by a dermatologist before you treat. Dr. Lautenschläger is clear on this: diagnosing skin disease isn’t the cosmetic practitioner’s job, and atopic skin is a medical indication (Lautenschläger, Crossing borders). Decisions about steroids or any other medication belong with the prescribing doctor. Advising a client to stop a prescription, or to manage her eczema through diet and supplements, puts her at risk and takes your practice outside its scope.
What you can do is the part no prescription covers: rebuilding the barrier and calming inflammation every day, and making sure nothing in her routine is working against it. For clients under medical care, that work runs alongside their treatment, not in place of it. Lautenschläger calls this adjuvant corneotherapy. And between flares, consistent barrier care helps delay the next one.
What changes when you can support eczema skin
You stop turning these clients away. With a corneotherapeutic approach, your treatments work with the barrier instead of against it, so the skin stays calmer and flares are less likely. Home care becomes something clients trust, because they feel it working: skin that finally feels comfortable, and nights that aren’t interrupted by the itch. And a client whose skin finally feels manageable tends to stay, and to tell others.
Do you turn eczema clients away, or watch them flare after treatment? Let’s talk about how to support them.
Are you a licensed practitioner in New York State interested in becoming a dermaviduals provider? Inquire here.